Animal experiments, vital forces and courtrooms: Mateu Orfila, François Magendie and the study of poisons in nineteenth-century France.

The paper follows the lives of Mateu Orfila and François Magendie in early nineteenth-century Paris, focusing on their common interest in poisons. The first part deals with the striking similarities of their early careers: their medical training, their popular private lectures, and their first publications. The next section explores their experimental work on poisons by analyzing their views on physical and vital forces in living organisms and their ideas about the significance of animal experiments in medicine. The last part describes their contrasting research on the absorption of poisons and the divergences in their approaches, methods, aims, standards of proof, and intended audiences. The analysis highlights the connections between nineteenth-century courtrooms and experimental laboratories, and shows how forensic practice not only prompted animal experimentation but also provided a substantial body of information and new research methods for dealing with major theoretical issues like the absorption of poisons.

Arsenic: a beneficial therapeutic poison - a historical overview.

Arsenicals have been used since ancient Greek and Roman civilizations and in the Far East as part of traditional Chinese medicine. In Western countries, they became a therapeutic mainstay for various ailments and malignancies in the 19th and early 20th centuries. Fowler's potassium bicarbonate-based solution of arsenic trioxide (As2O3)solution was the main treatment of chronic myeloid leukaemia until the 1930s. After a decline in the use of arsenic during the mid-20th century, arsenic trioxide was reintroduced as an anticancer agent after reports emerged from China of the success of an arsenic trioxide-containing herbal mixture for the treatment of acute promyelocytic leukaemia. Arsenic trioxide was first purified and used in controlled studies in China in the 1970s.Subsequently, randomised clinical trials performed in the United States led to FDA approval of arsenic trioxide in the treatment of patients with relapsed or refractory acute promyelocytic leukaemia.

[The First School of Vienna and Samuel Hahnemann's pharmaceutical techniques]. / Der Einflub der Ersten Wiener Schule auf das Arzneiverständnis bei Samuel Hahnemann.

The First or Elder Vienna School of Medicine was initiated by Gerard van Swieten, the famous pupil of Herman Boerhaave. The aim of this school was to put medicine on new scientific foundations-promoting unprejudiced clinical observation, botanical and chemical research, and the introduction of simple but powerful remedies. One of the products of this school was Anton Störck (1731-1803), appointed Director of Austrian public health and medical education by Empress Maria Theresia. Following the tradition of the Vienna School, Störck was the first scientist to systematically test the effects of so-called poisonous plants (e.g., hemlock, henbane, meadow saffron). Discovering new therapeutic properties in previously dreaded plants, Störck used himself as a subject in experiments to determine tolerable dose levels. As a result of his investigations, Störck was able to successfully treat his patients using the drugs he discovered. Samuel Hahnemann's later writings, including his "Organon", show that he was considerably influenced by Störck's ideas. In fact, Hahnemann's clinical teacher at Vienna was a follower of Störck, Joseph Quarin. Hahnemann's elaborate system of validating homeopath material can be seen as a development and refinement of the techniques he learned in Vienna.